Found: 76
Select item for more details and to access through your institution.
The association of diabetes mellitus and routinely collected patient‐reported outcomes in patients with cancer. A real‐world cohort study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 20, p. 1, doi. 10.1002/cam4.70246
- By:
- Publication type:
- Article
Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Caregiver burden by treatment and clinical characteristics of patients with glioblastoma.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 2, p. 1365, doi. 10.1007/s00520-021-06514-0
- By:
- Publication type:
- Article
First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma.
- Published in:
- Cancer Reports, 2021, v. 4, n. 6, p. 1, doi. 10.1002/cnr2.1419
- By:
- Publication type:
- Article
An evaluation of biobanking and therapeutic clinical trial representation among adult glioma patients from rural and urban Utah.
- Published in:
- Neuro-Oncology Practice, 2023, v. 10, n. 5, p. 472, doi. 10.1093/nop/npad026
- By:
- Publication type:
- Article
Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.
- Published in:
- Stem Cells, 2015, v. 33, n. 8, p. 2400, doi. 10.1002/stem.2053
- By:
- Publication type:
- Article
A High Notch Pathway Activation Predicts Response to γ Secretase Inhibitors in Proneural Subtype of Glioma Tumor-Initiating Cells.
- Published in:
- Stem Cells, 2014, v. 32, n. 1, p. 301, doi. 10.1002/stem.1528
- By:
- Publication type:
- Article
Effective Elimination of Cancer Stem Cells By a Novel Drug Combination Strategy.
- Published in:
- Stem Cells, 2013, v. 31, n. 1, p. 23, doi. 10.1002/stem.1273
- By:
- Publication type:
- Article
REST Regulates Oncogenic Properties of Glioblastoma Stem Cells.
- Published in:
- Stem Cells, 2012, v. 30, n. 3, p. 405, doi. 10.1002/stem.1020
- By:
- Publication type:
- Article
DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.
- Published in:
- Acta Neuropathologica Communications, 2015, v. 3, n. 1, p. 1, doi. 10.1186/s40478-015-0213-3
- By:
- Publication type:
- Article
Intermittent Induction of HIF-1α Produces Lasting Effects on Malignant Progression Independent of Its Continued Expression.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0125125
- By:
- Publication type:
- Article
Exploratory Analysis of the Copy Number Alterations in Glioblastoma Multiforme.
- Published in:
- PLoS ONE, 2008, v. 3, n. 12, p. 1, doi. 10.1371/journal.pone.0004076
- By:
- Publication type:
- Article
Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments.
- Published in:
- Current Oncology Reports, 2011, v. 13, n. 1, p. 42, doi. 10.1007/s11912-010-0144-x
- By:
- Publication type:
- Article
New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M.
- Published in:
- Current Neurology & Neuroscience Reports, 2017, v. 17, n. 2, p. 1, doi. 10.1007/s11910-017-0722-5
- By:
- Publication type:
- Article
IDH1 and IDH2 Mutations in Gliomas.
- Published in:
- Current Neurology & Neuroscience Reports, 2013, v. 13, n. 5, p. 1, doi. 10.1007/s11910-013-0345-4
- By:
- Publication type:
- Article
The Raman effect on intraoperative diagnosis of central nervous system tumors.
- Published in:
- Neurosurgical Focus, 2022, v. 53, n. 6, p. 1, doi. 10.3171/2022.9.FOCUS22440
- By:
- Publication type:
- Article
Update on neuro-oncology.
- Published in:
- Neurosurgical Focus, 2022, v. 53, n. 6, p. 1, doi. 10.3171/2022.9.FOCUS22437
- By:
- Publication type:
- Article
INTRODUCTION: Update on adult neuro-oncology.
- Published in:
- Neurosurgical Focus, 2018, v. 44, n. 6, p. 1, doi. 10.3171/2018.3.FOCUS18149
- By:
- Publication type:
- Article
Potential survival benefit of resection in butterfly glioblastoma.
- Published in:
- Neurosurgical Focus, 2018, v. 44, n. 6, p. 1, doi. 10.3171/2018.3.FOCUS18152
- By:
- Publication type:
- Article
Medulloblastoma: Molecular Classifications and Prognostic Associations.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1097
- By:
- Publication type:
- Article
Examination of the Therapeutic Potential of Delta-24-RGD in Brain Tumor Stem Cells: Role of Autophagic Cell Death.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 18, p. 1410, doi. 10.1093/jnci/djm102
- By:
- Publication type:
- Article
Replicative Instability Drives Cancer Progression.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 11, p. 1570, doi. 10.3390/biom12111570
- By:
- Publication type:
- Article
Diabetes, Body Fatness, and Insulin Prescription Among Adolescents and Young Adults with Cancer.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2021, v. 10, n. 2, p. 217, doi. 10.1089/jayao.2020.0071
- By:
- Publication type:
- Article
The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors †.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 4913, doi. 10.3390/cancers15204913
- By:
- Publication type:
- Article
The transcriptional network for mesenchymal transformation of brain tumours.
- Published in:
- Nature, 2010, v. 463, n. 7279, p. 318, doi. 10.1038/nature08712
- By:
- Publication type:
- Article
Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 189, doi. 10.1093/neuonc/noaa253
- By:
- Publication type:
- Article
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1505, doi. 10.1093/neuonc/noaa062
- By:
- Publication type:
- Article
A platform for efficient early evaluation of biomarker-associated therapies in newly diagnosed IDH wild-type, MGMT unmethylated glioblastoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 1, p. 6, doi. 10.1093/neuonc/noy190
- By:
- Publication type:
- Article
TMOD-19. MUTANT IDH1 PROMOTES GLIOMA FORMATION IN VIVO.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi272, doi. 10.1093/neuonc/noy148.1131
- By:
- Publication type:
- Article
PATH-54. UTILITY OF NEXT GENERATION SEQUENCING IN ADULT PRIMARY BRAIN TUMORS: IMPACT ON DIAGNOSIS AND PERSONALIZED THERAPY.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi170, doi. 10.1093/neuonc/noy148.708
- By:
- Publication type:
- Article
COMP-20. THE NON-INVASIVE DETECTION OF GLIOBLASTOMA-DERIVED CELL-FREE DNA IN PLASMA USING NEXT-GENERATION SEQUENCING AND AN UNTARGETED VARIANT SEARCH.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi67, doi. 10.1093/neuonc/noy148.275
- By:
- Publication type:
- Article
ATIM-24. INTERIM RESULTS OF A PHASE II MULTICENTER STUDY OF THE CONDITIONALLY REPLICATIVE ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB (KEYTRUDA) FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192).
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi6, doi. 10.1093/neuonc/noy148.019
- By:
- Publication type:
- Article
HOUT-01. A RETROSPECTIVE ANALYSIS OF OUTCOMES WITH TEMOZOLOMIDE AS INITIAL TREATMENT OF GRADE 2 OLIGODENDROGLIOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi113, doi. 10.1093/neuonc/noy148.469
- By:
- Publication type:
- Article
Toward more informative biomarker-based clinical trials in glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 7, p. 880, doi. 10.1093/neuonc/nox063
- By:
- Publication type:
- Article
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 4, p. 557, doi. 10.1093/neuonc/nov245
- By:
- Publication type:
- Article
Toward precision medicine in glioblastoma: the promise and the challenges.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 8, p. 1051, doi. 10.1093/neuonc/nov031
- By:
- Publication type:
- Article
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 3, p. 440, doi. 10.1093/neuonc/nou162
- By:
- Publication type:
- Article
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 2, p. 266, doi. 10.1093/neuonc/nou155
- By:
- Publication type:
- Article
PHASE II TRIAL OF THE PHOSPHATIDYINOSITOL-3 KINASE (PI3K) INHIBITOR BUPARLISIB (BKM120) IN RECURRENT GLIOBLASTOMA CONDUCTED BY THE IVY FOUNDATION EARLY PHASE CLINICAL TRIALS CONSORTIUM.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii47, doi. 10.1093/neuonc/nou209.20
- By:
- Publication type:
- Article
DISTINCT COPY NUMBER ALTERATIONS AND INCIDENCE OF CHROMOTHRIPSIS ASSOCIATED WITH GRADE AND PROGNOSIS IN IDH MUTANT AND WILD-TYPE GLIOMAS.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii6, doi. 10.1093/neuonc/nou206.20
- By:
- Publication type:
- Article
Experimental validation of 5 in-silico predicted glioma biomarkers.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 12, p. 1625, doi. 10.1093/neuonc/not124
- By:
- Publication type:
- Article
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 11, p. 1167, doi. 10.1093/neuonc/noq100
- By:
- Publication type:
- Article
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 2, p. 116, doi. 10.1093/neuonc/nop020
- By:
- Publication type:
- Article
A multigene predictor of outcome in glioblastoma.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 1, p. 49, doi. 10.1093/neuonc/nop007
- By:
- Publication type:
- Article
Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 7, p. 1468, doi. 10.1002/cncr.21338
- By:
- Publication type:
- Article
The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdab186
- By:
- Publication type:
- Article
Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First Report.
- Published in:
- Case Reports in Oncology, 2013, v. 6, n. 2, p. 434, doi. 10.1159/000354753
- By:
- Publication type:
- Article
Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, Irinotecan.
- Published in:
- Glycoconjugate Journal, 2010, v. 27, n. 1, p. 27, doi. 10.1007/s10719-009-9249-6
- By:
- Publication type:
- Article